Foghorn Therapeutics Inc. (FHTX) Misses Q1 EPS by 1c

Foghorn Therapeutics Inc. (NASDAQ: FHTX) reported Q1 EPS of ($0.29), $0.01 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $3.26 million versus the consensus estimate of $9.35 million.

For earnings history and earnings-related data on Foghorn Therapeutics Inc. (FHTX) click here.

You May Also Be Interested In

• Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case
• lululemon athletica (LULU) call put ratio 1 call to 1.3 puts into quarter results
• PVH Corp. (PVH) call put ratio 1.4 calls to 1 put into quarter results